Adolescents with a particular variant of an opioid receptor have less response to a part of the prefrontal cortex that evaluates rewards, compared to those with the other version of the gene, say at Georgetown University Medical Center (GUMC)
All news from Medical Genetics
The number of severe maternal morbidities (SMM) a pregnant woman has been linked to her risk of maternal death, according to a study by ICES and St. Michael's Hospital. SMM is defined by potentially life-threatening conditions such as ICU admission, invasive ventilation, and cardiac conditions that develop during pregnancy
Although Bangladesh attained remarkable success in curbing child mortality rate over the last 25 years, more than six hundred thousand are born prematurely each year in Bangladesh. Awareness about health and nutrition of mothers is important to decrease premature birth, discussants at a roundtable observed.
With the government's implementation of the Ayushman Bharat-National Health Protection Mission in September 2018, the health insurance sector in India stands to gain like never before. A health policy for the socio-economically underprivileged sections of the country, Ayushman Bharat will likely benefit nearly 500 million Indians or 100 million families, by providing them with health insurance of up to Rs 5 lakh per year. Although the underlying framework for the scheme's pricing and delivery is still under consideration, the central and state governments will finance it.
An international research team led by members of the University of Colorado School of Medicine faculty has identified a genetic connection between rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis. The findings are published in the current issue of the New England Journal of Medicine.
Use of angiotensin converting enzyme inhibitor drugs (ACEIs) to lower blood pressure is associated with an increased risk of lung cancer compared with use of another group of blood pressure drugs called angiotensin receptor blockers (ARBs), finds a study in The BMJ.
A new, $ 17.8 million grant will ensure USC remains at the forefront of research to protect people from tobacco-related health risks. The money will be used to promote biomedical and behavioral research to build the scientific underpinning for regulation of tobacco products . USC is part of a national, federally funded program to assess and prevent harm from tobacco products.
A cluster of factors may help predict which patients are likely to develop Clostridioides difficile, a potentially life-threatening disease commonly known as C. difficile or C. diff, a new study has found. And that could help in efforts to prevent infection, according to the researchers. The study appears in the journal Science Translational Medicine.
A University of Texas at Arlington electrical engineer is working in collaboration with a pioneer in the field to develop an implantable optical probe that can be inserted in the brain and used to monitor brain function after traumatic injuries or surgeries, then be absorbed by the body. If successful, the device would increase patient comfort during recovery and lessen the risks of complications from surgery to remove monitoring devices.
The winner of the Johanna Duermueller-Bol DBMR Research Award 2018 is Dr. Stephanie Ganal-Vonarburg. As a Senior Scientist, she conducts research in the Gastroenterology / Mucosal Immunology Research Laboratory at Bern University Hospital and at the Department for BioMedical Research at the University of Bern. Ganal-Vonarburg is being awarded for its research in the field of commensal microbiota – the microbes in the intestine.
A study published in The Lancet HIV shows that HIV-2 is more pathogenic than previously demonstrated. The new findings indicate that treatment should be applied to all patients with HIV, not only to those with HIV-1.
InDevR announced that it will follow proof of concept development for new VaxArray potency assays for measles (M) and rubella vaccines sponsored by the Bill & Melinda Gates Foundation.
The long-term objective is to create in vitro measles and rubella potency assays in order to deliver high-quality MR vaccines to market faster and with lower production costs. The project will leverage the multiplexed VaxArray platform, which was first developed and validated for more efficient potency testing of influenza vaccines.